This journal is not listed in the SCIE, SSCI, AHCI, ESCI, Scopus or JCR 2024 lists. That does not make it unreliable, but check its indexing, peer review and fees carefully.
How to spot predatory journals →01Impact factor
Impact factor of Cardiovascular & Haematological Disorders - Drug Targets (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Cardiovascular & Haematological Disorders - Drug Targets published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is not listed in JCR 2024, so it has no official Journal Impact Factor from Clarivate; the value above is how often its recent papers are cited.
Rank in its subject categories
- Pharmacology & Pharmacyrank 290 of 371 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Cardiovascular & Haematological Disorders - Drug Targets
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Cardiovascular & Haematological Disorders - Drug Targets is not listed in JCR 2024, so it has no JCR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Is your paper a fit for Cardiovascular & Haematological Disorders - Drug Targets?
Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.
Check my paper for this journalOr find journals that fit my paper
02Review time
Review time of Cardiovascular & Haematological Disorders - Drug Targets
Each paper took a different time. The green box holds the middle half of the papers and the dark line is the median; the whiskers reach the fastest 10% and the slowest 10%. Plan with the whole spread, not only the median.
Half of the research articles Cardiovascular & Haematological Disorders - Drug Targets published between Nov 2024 and Nov 2026 were accepted within 91 days of submission, and the middle half took between 66 and 110 days. This time includes peer review and any revision rounds. Papers that were rejected are not counted, because only published papers carry these dates.
In Pharmacology & Pharmacy, Cardiovascular & Haematological Disorders - Drug Targets ranks 47 of 157 journals by review time (1 = fastest). See the fastest-review journals in Pharmacology & Pharmacy →
Need a faster review? Cardiovascular & Haematological Disorders - Drug Targets takes a median of 91 days; the fastest journals in Pharmacology & Pharmacy take 3.
APC waivers and discounts for Cardiovascular & Haematological Disorders - Drug Targets
No published waiver policy found for its publisher. Ask the editorial office, and compare publishers that do waive the APC.
03Funders
Who funds research published in Cardiovascular & Haematological Disorders - Drug Targets
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
04Indexing
Indexing of Cardiovascular & Haematological Disorders - Drug Targets
| List | Status |
|---|---|
| Science Citation Index Expanded (SCIE) | Not listed |
| Social Sciences Citation Index (SSCI) | Not listed |
| Arts & Humanities Citation Index (AHCI) | Not listed |
| Emerging Sources Citation Index (ESCI) | Not listed |
| Scopus | Not listed |
| Journal Citation Reports 2024 | Not listed |
- ISSN
- 1568-0061
- eISSN
- 1871-529X
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
05How to submit
How to submit to Cardiovascular & Haematological Disorders - Drug Targets
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Cardiovascular & Haematological Disorders - Drug Targets accepts. You find it on the journal's website, usually under "For authors".
- Format to the journal's style. Check whether it wants a Word file, a LaTeX file or a PDF for the first submission, and follow its reference style; many journals accept any clear format at first and ask for their style only after acceptance. If the language or structure needs work first, manuscript editing by a PhD editor in your field is priced by word count (see the editing cost guide).
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. Cardiovascular & Haematological Disorders - Drug Targets is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
06Reviewer comments
Reviewer comments and rejection reasons for Cardiovascular & Haematological Disorders - Drug Targets
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Cardiovascular & Haematological Disorders - Drug Targets, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Worried about the English? Manuscript editing by editors in your subject: see the price →
Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds07Same subject
Pharmacology & Pharmacy journals with a similar impact factor*
The journals next to Cardiovascular & Haematological Disorders - Drug Targets when the 354 journals of Pharmacology & Pharmacy in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 286 | JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY | 1.28 | ESCI | Subscription |
| 287 | Oriental Pharmacy and Experimental Medicine | 1.27 | ESCI | Subscription |
| 288 | International Journal of Pharmaceutical Investigation | 1.26 | ESCI | Subscription |
| 289 | Journal of Pharmaceutical Innovation | 1.20 | SCIE | Subscription |
| 291 | European Journal of Hospital Pharmacy | 1.19 | SCIE | Subscription |
| 292 | Alcohol | 1.19 | SCIE | Subscription |
| 293 | Chinese Medicine | 1.19 | SCIE | Some open access |
| 294 | Therapies | 1.17 | SCIE | Subscription |
*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.
Is Cardiovascular & Haematological Disorders - Drug Targets right for your paper? Find the right journal
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 157,397 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.
08Questions
Frequently asked questions
How long is the review time of Cardiovascular & Haematological Disorders - Drug Targets?
Based on 95 research articles Cardiovascular & Haematological Disorders - Drug Targets published from Nov 2024 to Nov 2026, the median time from submission to acceptance was 91 days, and half of them were accepted between 66 and 110 days. After acceptance, papers appeared online after a median of 216 days. Data updated October 2026. Individual papers can take longer, especially with major revisions.
What is the impact factor of Cardiovascular & Haematological Disorders - Drug Targets?
Based on ScholarsColab citation data (October 2026), the 2-year impact factor of Cardiovascular & Haematological Disorders - Drug Targets is 1.20: papers it published in the two previous years were cited 1.20 times on average in a year. The journal is not listed in JCR 2024, so it has no official Clarivate Journal Impact Factor.
What is the h-index of Cardiovascular & Haematological Disorders - Drug Targets?
The h-index of Cardiovascular & Haematological Disorders - Drug Targets is 52 (October 2026): 52 of its papers have each been cited at least 52 times. Its i10-index is 314.
What is the quartile of Cardiovascular & Haematological Disorders - Drug Targets?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Cardiovascular & Haematological Disorders - Drug Targets is not listed in JCR 2024, so it has no JCR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Cardiovascular & Haematological Disorders - Drug Targets indexed in Scopus?
Cardiovascular & Haematological Disorders - Drug Targets is not listed in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Cardiovascular & Haematological Disorders - Drug Targets an SCIE journal?
Cardiovascular & Haematological Disorders - Drug Targets is not listed in SCIE or the other Web of Science indexes, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Cardiovascular & Haematological Disorders - Drug Targets in Journal Citation Reports (JCR)?
Cardiovascular & Haematological Disorders - Drug Targets is not listed in the JCR 2024 list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Who funds research published in Cardiovascular & Haematological Disorders - Drug Targets?
2% of 100 recent research articles in Cardiovascular & Haematological Disorders - Drug Targets name a funder; the funders named most often are CONAHCYT FORDECYT-PRONACES, PAPIIT, DGAPA, UNAM, Guangxi University of Chinese Medicine.
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Physical Review C
- Materials Letters
- Science of the Total Environment
- Physical Chemistry Chemical Physics
- Journal of Colloid and Interface Science
- Transplantation
- Industrial and Engineering Chemistry Research
- Solid State Communications
- Nature Communications
- Materials Science and Engineering: A
- Applied Optics
- Journal of Agricultural and Food Chemistry
- Journal of Animal Science
- Japanese Journal Of Applied Physics
Browse all journals: indexing, impact factor and reviewer comments →